Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies
- 1 March 1969
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 46 (3) , 330-343
- https://doi.org/10.1016/0002-9343(69)90036-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Studies of Muramidase (Lysozyme) in LeukemiaJAMA, 1968
- The active site of lysozyme ; some properties of subsites E and FBiochemical and Biophysical Research Communications, 1967
- SERUM AND URINARY LYSOZYME (MURAMIDASE) IN MONOCYTIC AND MONOMYELOCYTIC LEUKEMIAThe Journal of Experimental Medicine, 1966
- Extensive Histological and Cytological Survey of Patients with Acute Leukaemia in "Complete Remission"BMJ, 1966
- A Study of Urinary and Serum Lysozyme in Patients with Renal DiseaseNew England Journal of Medicine, 1964
- Extensive Leukemic Infiltration of the Gastrointestinal Tract during Apparent Remission in Acute LeukemiaBlood, 1963
- The structure of di- and tetra-saccharides released from cell walls by lysozyme and streptomyces F1 enzyme and the β (1→4) N-acetylhexosaminidase activity of these enzymesBiochimica et Biophysica Acta, 1959
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955
- THE DETERMINATION OF LYSOZYMEJournal of Bacteriology, 1949
- Lysozyme activity in ulcerative alimentary diseaseThe American Journal of Medicine, 1948